Cargando…

Comparison of Postoperative Nausea and Vomiting Incidence between Remimazolam and Sevoflurane in Tympanoplasty with Mastoidectomy: A Single-Center, Double-Blind, Randomized Controlled Trial

Background and Objectives: Postoperative nausea and vomiting (PONV) is a common adverse effect of general anesthesia, especially in middle ear surgery. Remimazolam is a newer benzodiazepine recently approved for use in general anesthesia. This study aimed to compare the incidence rate of PONV after...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Seung Cheol, Jung, Ji Wook, Choi, So Ron, Chung, Chan Jong, Lee, Tae Young, Park, Sang Yoong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383232/
https://www.ncbi.nlm.nih.gov/pubmed/37512009
http://dx.doi.org/10.3390/medicina59071197
_version_ 1785080857760890880
author Lee, Seung Cheol
Jung, Ji Wook
Choi, So Ron
Chung, Chan Jong
Lee, Tae Young
Park, Sang Yoong
author_facet Lee, Seung Cheol
Jung, Ji Wook
Choi, So Ron
Chung, Chan Jong
Lee, Tae Young
Park, Sang Yoong
author_sort Lee, Seung Cheol
collection PubMed
description Background and Objectives: Postoperative nausea and vomiting (PONV) is a common adverse effect of general anesthesia, especially in middle ear surgery. Remimazolam is a newer benzodiazepine recently approved for use in general anesthesia. This study aimed to compare the incidence rate of PONV after tympanoplasty with mastoidectomy between using remimazolam and sevoflurane. Materials and Methods: This study included 80 patients undergoing elective tympanoplasty with mastoidectomy. The patients were randomly assigned to either the remimazolam or sevoflurane group. The primary outcome was the incidence rate of PONV 12 h after surgery. The secondary outcomes were the incidence rate of PONV 12–24 and 24–48 h after surgery, severity of PONV, incidence rate of vomiting, administration of rescue antiemetics, hemodynamic stability, and recovery profiles. Results: The incidence rate of PONV 0–12 h after tympanoplasty with mastoidectomy was significantly lower in the remimazolam group compared with that in the sevoflurane group (28.9 vs. 57.9%; p = 0.011). However, the incidence rate of delayed PONV did not differ between the two groups. PONV severity in the early periods after the surgery was significantly lower in the remimazolam group than in the sevoflurane group. The incidence rate of adverse hemodynamic events was lower in the remimazolam group than in the sevoflurane group, but there was no difference in the overall trends of hemodynamic data between the two groups. There was no difference in recovery profiles between the two groups. Conclusions: Remimazolam can significantly reduce the incidence rate of early PONV after tympanoplasty with mastoidectomy under general anesthesia.
format Online
Article
Text
id pubmed-10383232
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-103832322023-07-30 Comparison of Postoperative Nausea and Vomiting Incidence between Remimazolam and Sevoflurane in Tympanoplasty with Mastoidectomy: A Single-Center, Double-Blind, Randomized Controlled Trial Lee, Seung Cheol Jung, Ji Wook Choi, So Ron Chung, Chan Jong Lee, Tae Young Park, Sang Yoong Medicina (Kaunas) Article Background and Objectives: Postoperative nausea and vomiting (PONV) is a common adverse effect of general anesthesia, especially in middle ear surgery. Remimazolam is a newer benzodiazepine recently approved for use in general anesthesia. This study aimed to compare the incidence rate of PONV after tympanoplasty with mastoidectomy between using remimazolam and sevoflurane. Materials and Methods: This study included 80 patients undergoing elective tympanoplasty with mastoidectomy. The patients were randomly assigned to either the remimazolam or sevoflurane group. The primary outcome was the incidence rate of PONV 12 h after surgery. The secondary outcomes were the incidence rate of PONV 12–24 and 24–48 h after surgery, severity of PONV, incidence rate of vomiting, administration of rescue antiemetics, hemodynamic stability, and recovery profiles. Results: The incidence rate of PONV 0–12 h after tympanoplasty with mastoidectomy was significantly lower in the remimazolam group compared with that in the sevoflurane group (28.9 vs. 57.9%; p = 0.011). However, the incidence rate of delayed PONV did not differ between the two groups. PONV severity in the early periods after the surgery was significantly lower in the remimazolam group than in the sevoflurane group. The incidence rate of adverse hemodynamic events was lower in the remimazolam group than in the sevoflurane group, but there was no difference in the overall trends of hemodynamic data between the two groups. There was no difference in recovery profiles between the two groups. Conclusions: Remimazolam can significantly reduce the incidence rate of early PONV after tympanoplasty with mastoidectomy under general anesthesia. MDPI 2023-06-25 /pmc/articles/PMC10383232/ /pubmed/37512009 http://dx.doi.org/10.3390/medicina59071197 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Lee, Seung Cheol
Jung, Ji Wook
Choi, So Ron
Chung, Chan Jong
Lee, Tae Young
Park, Sang Yoong
Comparison of Postoperative Nausea and Vomiting Incidence between Remimazolam and Sevoflurane in Tympanoplasty with Mastoidectomy: A Single-Center, Double-Blind, Randomized Controlled Trial
title Comparison of Postoperative Nausea and Vomiting Incidence between Remimazolam and Sevoflurane in Tympanoplasty with Mastoidectomy: A Single-Center, Double-Blind, Randomized Controlled Trial
title_full Comparison of Postoperative Nausea and Vomiting Incidence between Remimazolam and Sevoflurane in Tympanoplasty with Mastoidectomy: A Single-Center, Double-Blind, Randomized Controlled Trial
title_fullStr Comparison of Postoperative Nausea and Vomiting Incidence between Remimazolam and Sevoflurane in Tympanoplasty with Mastoidectomy: A Single-Center, Double-Blind, Randomized Controlled Trial
title_full_unstemmed Comparison of Postoperative Nausea and Vomiting Incidence between Remimazolam and Sevoflurane in Tympanoplasty with Mastoidectomy: A Single-Center, Double-Blind, Randomized Controlled Trial
title_short Comparison of Postoperative Nausea and Vomiting Incidence between Remimazolam and Sevoflurane in Tympanoplasty with Mastoidectomy: A Single-Center, Double-Blind, Randomized Controlled Trial
title_sort comparison of postoperative nausea and vomiting incidence between remimazolam and sevoflurane in tympanoplasty with mastoidectomy: a single-center, double-blind, randomized controlled trial
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383232/
https://www.ncbi.nlm.nih.gov/pubmed/37512009
http://dx.doi.org/10.3390/medicina59071197
work_keys_str_mv AT leeseungcheol comparisonofpostoperativenauseaandvomitingincidencebetweenremimazolamandsevofluraneintympanoplastywithmastoidectomyasinglecenterdoubleblindrandomizedcontrolledtrial
AT jungjiwook comparisonofpostoperativenauseaandvomitingincidencebetweenremimazolamandsevofluraneintympanoplastywithmastoidectomyasinglecenterdoubleblindrandomizedcontrolledtrial
AT choisoron comparisonofpostoperativenauseaandvomitingincidencebetweenremimazolamandsevofluraneintympanoplastywithmastoidectomyasinglecenterdoubleblindrandomizedcontrolledtrial
AT chungchanjong comparisonofpostoperativenauseaandvomitingincidencebetweenremimazolamandsevofluraneintympanoplastywithmastoidectomyasinglecenterdoubleblindrandomizedcontrolledtrial
AT leetaeyoung comparisonofpostoperativenauseaandvomitingincidencebetweenremimazolamandsevofluraneintympanoplastywithmastoidectomyasinglecenterdoubleblindrandomizedcontrolledtrial
AT parksangyoong comparisonofpostoperativenauseaandvomitingincidencebetweenremimazolamandsevofluraneintympanoplastywithmastoidectomyasinglecenterdoubleblindrandomizedcontrolledtrial